Get started

Financials · NHTC

Natural Health Trends Corp. (NHTC) financials

For the twelve months ended Sep 30, 2026, Natural Health Trends Corp. reported $34.12M of revenue and -$1.43M of net income.

Revenue, TTM
$34.12M
Revenue growth, YoY
-16.5%
Net income, TTM
-$1.43M
Net margin
-4.2%
Free cash flow, TTM
-$4.66M
EPS, diluted, TTM
-$0.15
Cash
$5.82M
P/S
0.18
Market cap
$6.3M
Annual revenue$39.78M
FY2017FY2025
Annual net income-$882.0K
FY2016FY2025
Annual free cash flow-$6.07M
FY2016FY2025

NHTC revenue and earnings growth

NHTC revenueQ3 2026$7.56M

Quarter YoY
-20.2%
QoQ
-0.6%
FY YoY
-7.4%
5Y CAGR
-8.5%

NHTC revenue was $7.56M in fiscal Q3 2026 (ended Sep 30, 2026), down 20.2% from a year earlier and down 0.6% from the prior quarter. For the full fiscal 2025 it was $39.78M, down 7.4% from fiscal 2024. Compound annual growth was -8.5% over 5 years. It rose in 0 of the last 8 fiscal years.

NHTC net incomeQ3 2026-$232.0K

NHTC net income was -$232.0K in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$431.0K a year earlier. For the full fiscal 2025 it was -$882.0K, compared with $572.0K in fiscal 2024.

NHTC EPSQ3 2026-$0.03

NHTC diluted EPS was -$0.03 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.04 a year earlier. For the full fiscal 2025 it was -$0.08, compared with $0.05 in fiscal 2024.

NHTC free cash flowQ3 2026-$1.10M

NHTC free cash flow was -$1.10M in fiscal Q3 2026 (ended Sep 30, 2026), compared with $70.0K a year earlier. For the full fiscal 2025 it was -$6.07M, compared with -$3.42M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$39.78M$42.96M$43.92M$49.13M$60.01M$62.07M$77.61M$191.91M$197.56M-
Cost of revenue$10.52M$11.18M$11.18M$12.66M$15.01M$16.99M$20.10M$39.37M$38.65M$54.90M
Gross profit$29.25M$31.79M$32.75M$36.47M$44.99M$45.08M$57.51M$152.54M$158.92M$232.82M
Selling, general and admin$14.76M$15.51M$16.01M$16.00M$17.85M$18.21M$27.22M$31.31M$32.22M$43.24M
Operating income-$1.81M-$1.30M-$1.67M-$270.0K$1.57M$669.0K-$7.02M$33.73M$43.06M$64.14M
Pre-tax income-$567.0K$620.0K$745.0K$602.0K$1.51M$1.49M-$5.60M$34.52M$43.43M$64.08M
Income tax$315.0K$48.0K$177.0K$289.0K$425.0K$647.0K$14.0K$3.49M$19.85M$8.99M
Net income-$882.0K$572.0K$568.0K$313.0K$1.08M$843.0K-$5.61M$31.04M$23.58M$55.09M
EPS, basic-$0.08$0.05$0.05$0.03$0.10$0.08-$0.52$2.75$2.10$4.84
EPS, diluted-$0.08$0.05$0.05$0.03$0.09$0.07-$0.52$2.74$2.09$4.83
Diluted shares11.5M11.5M11.5M11.4M11.4M11.4M10.9M11.3M11.3M11.4M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$6.81M$13.53M$56.18M$69.67M$83.84M$92.37M$96.03M$135.65M$138.48M$128.88M
Short-term investments$22.06M$30.41M$0-------
Inventory$2.05M$3.27M$4.29M$4.53M$5.26M$3.78M$6.40M$12.16M$8.40M$11.26M
Current assets$34.19M$50.98M$64.23M$77.55M$93.47M$99.74M$108.38M$150.19M$151.24M$141.24M
Goodwill------$0$1.76M$1.76M$1.76M
Total assets$38.43M$55.36M$69.09M$82.82M$98.36M$105.94M$118.50M$157.92M$159.55M$148.05M
Current liabilities$13.69M$20.80M$19.98M$20.44M$24.66M$21.51M$26.30M$43.08M$41.92M$57.15M
Total liabilities$15.00M$22.49M$27.49M$32.67M$38.87M$38.24M$43.43M$68.06M$68.93M$65.61M
Shareholders' equity$23.43M$32.87M$41.60M$50.15M$59.49M$67.70M$75.06M$89.86M$90.62M$82.44M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$6.00M-$3.37M-$4.28M-$4.85M$1.02M$1.89M-$18.64M$29.71M$26.61M$53.17M
Capital expenditures$68.0K$57.0K$46.0K$143.0K$225.0K$211.0K$189.0K$214.0K$278.0K$905.0K
Free cash flow-$6.07M-$3.42M-$4.32M-$5.00M$791.0K$1.67M-$18.83M$29.50M$26.33M$52.27M
Investing cash flow$8.15M-$30.07M-$46.0K-$143.0K-$225.0K-$211.0K-$189.0K-$214.0K-$278.0K-$905.0K
Financing cash flow-$9.21M-$9.21M-$9.21M-$9.14M-$9.14M-$9.14M-$17.46M-$31.51M-$17.22M-$30.59M
Dividends paid$9.21M$9.21M$9.21M$9.14M$9.14M$9.14M$7.34M$31.51M$17.22M$6.89M
Share repurchases-----$0$10.12M$0$0$23.70M
Stock-based compensation$132.0K$145.0K$161.0K$0---$0$35.0K$104.0K
Depreciation and amortization$109.0K$131.0K$164.0K$204.0K$299.0K$410.0K$387.0K-$536.0K$394.0K

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY-7.4%-2.2%-10.6%-18.1%-3.3%-20.0%-59.6%-2.9%--
Net income growth, YoY-0.7%81.5%-71.2%28.7%--31.6%-57.2%16.6%
EPS growth, YoY-0.0%66.7%-66.7%28.6%--31.1%-56.7%26.4%
Gross margin73.5%74.0%74.6%74.2%75.0%72.6%74.1%79.5%80.4%-
Operating margin-4.5%-3.0%-3.8%-0.5%2.6%1.1%-9.0%17.6%21.8%-
Net margin-2.2%1.3%1.3%0.6%1.8%1.4%-7.2%16.2%11.9%-
Free cash flow margin-15.2%-8.0%-9.8%-10.2%1.3%2.7%-24.3%15.4%13.3%-
Return on equity-3.8%1.7%1.4%0.6%1.8%1.2%-7.5%34.5%26.0%66.8%
Return on assets-2.3%1.0%0.8%0.4%1.1%0.8%-4.7%19.7%14.8%37.2%
Current ratio2.502.453.213.793.794.644.123.493.612.47

Source: XBRL data Natural Health Trends Corp. files with the SEC, latest filing dated Oct 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

NHTC peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
NHTC$34.12M-16.5%-$1.43M-4.2%$6.3M
SIG$6.82B+0.6%$353.80M5.2%$4.54B
CENT$3.08B-1.2%$166.31M5.4%$3.04B
CENTA$3.08B-1.2%$166.31M5.4%$2.60B
VSTS$2.70B-0.4%-$5.30M-0.2%$1.91B
MOV$689.87M+5.2%$41.38M6.0%$714.7M
FOSL$985.17M-9.1%-$69.87M-7.1%$476.7M
ELA$293.04M+47.7%$22.37M7.6%$274.2M
BRLT$451.83M+4.4%-$10.33M-2.3%$138.9M

NHTC FAQ

9 questions
  • What is NHTC revenue?
    Natural Health Trends Corp. (NHTC) reported $34.12M of revenue for the twelve months ended Sep 30, 2026. That is down 16.5% from the year before. Revenue for fiscal 2025 was $39.78M.
  • Is NHTC profitable?
    No. Natural Health Trends Corp. reported a net loss of $1.43M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does NHTC have?
    Natural Health Trends Corp. reported $5.82M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is NHTC revenue growing?
    Natural Health Trends Corp.'s revenue changed -7.4% in fiscal 2025, to $39.78M. Its compound annual growth rate was -8.5% over 5 years.
  • What is NHTC gross margin?
    Natural Health Trends Corp.'s gross profit was $25.34M on $34.12M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 74.3%.
  • What is NHTC free cash flow?
    Natural Health Trends Corp. generated -$4.66M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$4.21M less capital expenditures.
  • What is NHTC earnings per share?
    Diluted earnings per share were -$0.15 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did NHTC last report financial results?
    The latest statements here come from Natural Health Trends Corp.'s 10-Q filed on Oct 28, 2026, covering the period ended Sep 30, 2026.
  • Where does this NHTC financial data come from?
    Quantisnow builds these statements from the structured XBRL data Natural Health Trends Corp. files with the SEC. It is provided for information only and is not investment advice.